The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

Pilotto, S;Ferrara, R;Trisolini, R;Novello, S
2020-01-01

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
2020
Clinical practice guidelines
Metastatic disease
Non-small cell lung cancer
Recommendations
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Humans
Italy
Lung Neoplasms
Medical Oncology
Societies, Medical
Practice Guidelines as Topic
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1030198
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 41
social impact